Advancing Cell Therapies Through Diverse Tumor Models
Time: 2:00 pm
day: Day 1 Track B PM
Details:
- Challenges in evaluating allogeneic cell therapies preclinically
- Rationale of selecting different tumor models to assess allogeneic cell therapies
- Assessing strategies to improve infiltration and persistence in tumor microenvironment
